Fundraising Fox

Aponia Laboratories

Hampton, US · Founded 2010 · Delaware corporation

Aponia Laboratories is a specialized pharmaceutical company developing topical prescription and over-the-counter pain relief products based on ibuprofen for the NSAID segment of the arthritis pain market. Its products have completed formulation development and non-clinical studies and are undergoing FDA-guided clinical trials.

Founders & leadership

Aponia Laboratories was founded in 2010 by Kenneth M. Corroon and Robert J. Boolbol, M.D..

KM
Kenneth M. CorroonCo-founder, Chairman & CEO
RJ
Robert J. Boolbol, M.D.Co-founder & Director
EB
Elizabeth BoolbolExecutive

Board

DR
Daniel R McLeodBoard director
VK
VIKESH KUMARBoard director
RB
Robert BoolbolBoard director
JW
JEAN-PAUL WIENENBoard director
DB
David B McKaneBoard director
AK
Abhaya Kumar JainBoard director

Reported raises · per SEC filings

Form D private placements

$3.7M disclosed across 5 rounds · 2012–2024

$507.5KraisedApr 2025 · 2 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • DANIEL R MCLEODDirector
  • VIKESH KUMARDirector
  • ROBERT BOOLBOLDirector
  • JEAN-PAUL WIENENDirector
  • KENNETH M CORROONExecutive Officer, Director
  • DAVID B MCKANEDirector
Offering amount
$507.5K
Amount sold
$507.5K
Minimum investment
$10K
First sale
Apr 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$35KraisedOct 2021 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Vikesh KumarDirector
  • David B McKaneDirector
  • Robert BoolbolDirector
  • Kenneth M CorroonExecutive Officer, Director
  • Daniel R McLeodDirector
Offering amount
$35K
Amount sold
$35K
Minimum investment
$35K
First sale
Oct 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1.2MraisedMar 2015 · 2 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Daniel R McLeodDirector
  • Robert BoolbolDirector
  • David B McKaneDirector
  • Abhaya Kumar JainDirector
  • Kenneth M CorroonExecutive Officer, Director
Offering amount
$3.8M
Amount sold
$1.2M
Proceeds to insiders
$75K
First sale
Mar 2015
Incorporated
Corporation, Delaware, 2010
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1.5MraisedOct 2014 · 8 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Kenneth CorroonExecutive Officer, Director
Offering amount
$3.9M
Amount sold
$1.5M
Proceeds to insiders
$65K
First sale
Oct 2014
Incorporated
Corporation, Delaware, 2010
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$460KraisedMar 2012 · 4 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Elizabeth BoolbolExecutive Officer
  • Kenneth CorroonExecutive Officer, Director
  • David McKaneDirector
  • Robert BoolbolDirector
Offering amount
$1.8M
Amount sold
$460K
Proceeds to insiders
$40K
First sale
Feb 2012
Incorporated
Corporation, Delaware, 2010
Federal exemptions
06
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Companies competing with Aponia Laboratories for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Frequently asked questions

What does Aponia Laboratories do?
Aponia Laboratories is a specialized pharmaceutical company developing topical prescription and over-the-counter pain relief products based on ibuprofen for the NSAID segment of the arthritis pain market. Its products have completed formulation development and non-clinical studies and are undergoing FDA-guided clinical trials.
Who founded Aponia Laboratories?
Aponia Laboratories was founded by Kenneth M. Corroon, Robert J. Boolbol, M.D. in 2010.
How much funding has Aponia Laboratories raised?
Aponia Laboratories has disclosed $3.7M raised across 5 rounds.
Where is Aponia Laboratories headquartered?
Aponia Laboratories is headquartered in Hampton, US.